Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture Fludrocortisone Acetate Tablets USP, 0.1 mg from the United States Food and Drug ...

The promotor/promotors of Zydus Lifesciences Ltd are Pankaj R Patel, Sharvil P Patel, Mukesh M Patel, Apurva S Diwanji, Ganesh N Nayak, Bhadresh K Shah, Dhaval N Soni, Akhil A. Monappa ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Zydus Lifesciences: The drug maker has formalized a Memorandum of Agreement (MoA) with the Indian Council of Medical Research (ICMR) to initiate Phase 2 clinical trials of Desidustat in patients ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Fludrocortisone Acetate Tablets USP, 0.1 mg (USRLD: Florinef Tablets, 0.1 mg).

After hours: October 21 at 6:40 PM EDT ...

A division Bench of the Delhi High Court on Tuesday allowed Ahmedabad based Zydus Lifesciences’ to sell its breast cancer drug Sigrima. The order came amidst allegations that the drug is biologically ...

Zydus Lifesciences Ltd. (Formerly known as Cadila Healthcare Ltd.) is one of the leading innovation driven pharmaceutical companiesin India with presence across the pharmaceutical value chain ...

After hours: October 18 at 7:59 PM EDT ...

Zydus Lifesciences Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 102,882.39 Crore) operating in Pharmaceuticals sector. Zydus Lifesciences Ltd. key ...

Get up-to-the-minute news sent straight to your device.

Kohl's Corp. 3.84% $2.23B ...